Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias.
McLerran D, Grizzle WE, Feng Z, Bigbee WL, Banez LL, Cazares LH, Chan DW, Diaz J, Izbicka E, Kagan J, Malehorn DE, Malik G, Oelschlager D, Partin A, Randolph T, Rosenzweig N, Srivastava S, Srivastava S, Thompson IM, Thornquist M, Troyer D, Yasui Y, Zhang Z, Zhu L, Semmes OJ. McLerran D, et al. Among authors: troyer d. Clin Chem. 2008 Jan;54(1):44-52. doi: 10.1373/clinchem.2007.091470. Epub 2007 Nov 2. Clin Chem. 2008. PMID: 17981926 Free PMC article.
Prostate cancer prevention: what do we know now and when will we know more?
Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Thompson IM, et al. Among authors: troyer d. Clin Prostate Cancer. 2003 Mar;1(4):215-20. doi: 10.3816/cgc.2003.n.002. Clin Prostate Cancer. 2003. PMID: 15040879 Review.
The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology.
Grizzle WE, Semmes OJ, Basler J, Izbicka E, Feng Z, Kagan J, Adam BL, Troyer D, Srivastava S, Thornquist M, Zhang Z, Thompson IM. Grizzle WE, et al. Among authors: troyer d. Urol Oncol. 2004 Jul-Aug;22(4):337-43. doi: 10.1016/j.urolonc.2004.04.008. Urol Oncol. 2004. PMID: 15283893 Review.
Prognostic features in men who died of prostate cancer.
Thompson KE, Hernández J, Canby-Hagino ED, Troyer D, Thompson IM. Thompson KE, et al. Among authors: troyer d. J Urol. 2005 Aug;174(2):553-6; discussion 556. doi: 10.1097/01.ju.0000165184.72337.9d. J Urol. 2005. PMID: 16006890
Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Parekh DJ, et al. Among authors: troyer d. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1966-72. doi: 10.1158/1055-9965.EPI-07-0302. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17932343
307 results